Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Authors
Keywords
-
Journal
Brain Sciences
Volume 11, Issue 2, Pages 215
Publisher
MDPI AG
Online
2021-02-12
DOI
10.3390/brainsci11020215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
- (2020) Carina Wattmo et al. BMC Neurology
- The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
- (2020) Dimitrios A. Stakos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
- (2020) Sun Ah Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- The Contribution of Astrocyte Autophagy to Systemic Metabolism
- (2020) Ana Ortiz-Rodriguez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
- (2020) Steinunn Thordardottir et al. JOURNAL OF ALZHEIMERS DISEASE
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
- (2020) C. Delaby et al. Scientific Reports
- Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
- (2020) Unnur D. Teitsdottir et al. Alzheimers Research & Therapy
- Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
- (2020) Lenora Higginbotham et al. Science Advances
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
- (2019) Xue-Ning Shen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
- (2019) Scott Ayton et al. MOLECULAR PSYCHIATRY
- SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease
- (2019) Cristina Agliardi et al. MOLECULAR NEUROBIOLOGY
- Glial activation and inflammation along the Alzheimer’s disease continuum
- (2019) Kaja Nordengen et al. Journal of Neuroinflammation
- Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
- (2019) Suzanne E. Schindler et al. Alzheimers & Dementia
- Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
- (2019) Nicolas R. Barthélemy et al. Frontiers in Aging Neuroscience
- Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
- (2019) Anna Rita Zuena et al. Frontiers in Pharmacology
- α-synuclein in the pathophysiology of Alzheimer’s disease
- (2019) Daniel Twohig et al. Molecular Neurodegeneration
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
- (2019) Estrella Morenas-Rodríguez et al. Scientific Reports
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Blood circulating miRNAs as biomarkers of Alzheimer’s disease: a systematic review and meta-analysis
- (2019) Ya-Heng Zhang et al. Biomarkers in Medicine
- Role of miRNAs in Alzheimer's Disease and Possible Fields of Application
- (2019) Silvestro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
- (2019) Lieke Jäkel et al. Acta Neuropathologica Communications
- Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
- (2019) Anna Antonell et al. Alzheimers & Dementia
- When Does Alzheimer′s Disease Really Start? The Role of Biomarkers
- (2019) Lloret et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
- (2019) Mica T. M. Clarke et al. Alzheimers Research & Therapy
- CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
- (2019) Samir Abu-Rumeileh et al. Alzheimers Research & Therapy
- Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration
- (2019) Barry B. Muhoberac et al. Frontiers in Neuroscience
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
- (2018) Courtney L. Sutphen et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
- (2018) Erika Bereczki et al. BRAIN
- Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
- (2018) Spomenka Kiđemet-Piskač et al. CNS Neuroscience & Therapeutics
- Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer’s Disease
- (2018) Panagiotis Alexopoulos et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer’s Disease and Mild Cognitive Impairment
- (2018) Hua Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage
- (2018) Brianne M. Bettcher et al. JOURNAL OF ALZHEIMERS DISEASE
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
- (2018) Ilijana Begcevic et al. Journal of Proteomics
- MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
- (2018) Paul M. McKeever et al. MOLECULAR NEUROBIOLOGY
- Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
- (2018) Chao Peng et al. NEUROBIOLOGY OF DISEASE
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop
- (2018) C. E. Murray et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Ca 2+ -Triggered Synaptic Vesicle Fusion Initiated by Release of Inhibition
- (2018) Axel T. Brunger et al. TRENDS IN CELL BIOLOGY
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
- (2018) Ross W. Paterson et al. Alzheimers Research & Therapy
- Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
- (2018) Sylvain Lehmann et al. Frontiers in Aging Neuroscience
- Application of Metabolomics in Alzheimer’s Disease
- (2018) Jordan Maximillian Wilkins et al. Frontiers in Neurology
- Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia
- (2018) Audrey Gabelle et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease
- (2018) Michael Ewers et al. JOURNAL OF ALZHEIMERS DISEASE
- Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease
- (2018) Lisa M. Bloudek et al. JOURNAL OF ALZHEIMERS DISEASE
- The Role of Osteopontin in Neurodegenerative Diseases
- (2018) Miryam Carecchio et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ1-40 Improves Differential Dementia Diagnosis in Patients with Intermediate P-tau181P Levels
- (2018) Sylvie Slaets et al. JOURNAL OF ALZHEIMERS DISEASE
- α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
- (2018) Ane Korff et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease
- (2018) Barbara Mroczko et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNAs in Plasma and Cerebrospinal Fluid as Potential Markers for Alzheimer's Disease
- (2018) Takehiro Kiko et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
- (2018) Anna Antonell et al. JOURNAL OF ALZHEIMERS DISEASE
- Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
- (2018) Daniela Galimberti et al. JOURNAL OF ALZHEIMERS DISEASE
- Lack of Genetic Association Between TREM2 and Late-Onset Alzheimer's Disease in a Japanese Population
- (2018) Akinori Miyashita et al. JOURNAL OF ALZHEIMERS DISEASE
- Perturbed Iron Distribution in Alzheimer's Disease Serum, Cerebrospinal Fluid, and Selected Brain Regions: A Systematic Review and Meta-Analysis
- (2018) Yunlong Tao et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia
- (2018) Leonardo Tariciotti et al. JOURNAL OF ALZHEIMERS DISEASE
- The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
- (2018) Xianyuan Xiang et al. Molecular Neurodegeneration
- Regulation of microRNA function in animals
- (2018) Luca F. R. Gebert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
- (2018) Andrew J. Aschenbrenner et al. NEUROLOGY
- CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
- (2018) Shorena Janelidze et al. NEUROLOGY
- Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis
- (2018) Dan Liu et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
- (2018) Hua Zhang et al. Alzheimers Research & Therapy
- Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
- (2018) Jun-Lin Liu et al. Frontiers in Neuroscience
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
- (2018) Allison Kraus et al. ACTA NEUROPATHOLOGICA
- MicroRNAs and mild cognitive impairment: A systematic review
- (2018) Paola Piscopo et al. AGEING RESEARCH REVIEWS
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
- (2018) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD
- (2018) Daniel Alcolea et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- New insights into the role of TREM2 in Alzheimer’s disease
- (2018) Maud Gratuze et al. Molecular Neurodegeneration
- α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
- (2018) Inger van Steenoven et al. MOVEMENT DISORDERS
- TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
- (2018) Honghua Zheng et al. Frontiers in Aging Neuroscience
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
- (2018) Daniel Twohig et al. Acta Neuropathologica Communications
- Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathology
- (2018) Ibrahima Diouf et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
- (2017) Simone Lista et al. JOURNAL OF ALZHEIMERS DISEASE
- Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease
- (2017) Antero Salminen et al. JOURNAL OF NEUROCHEMISTRY
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
- (2017) Marta Querol-Vilaseca et al. Journal of Neuroinflammation
- Evidence that iron accelerates Alzheimer’s pathology: a CSF biomarker study
- (2017) Scott Ayton et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
- (2017) Rebecca Sims et al. NATURE GENETICS
- Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
- (2017) Simone Lista et al. NEUROCHEMISTRY INTERNATIONAL
- Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers
- (2017) Kaitlin B. Casaletto et al. NEUROLOGY
- CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
- (2017) Daniel Alcolea et al. NEUROLOGY
- Neurofilaments and Neurofilament Proteins in Health and Disease
- (2017) Aidong Yuan et al. Cold Spring Harbor Perspectives in Biology
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
- (2017) Nour K. Majbour et al. Scientific Reports
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
- (2017) Davide Chiasserini et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer’s Disease, But Has Similar Diagnostic Accuracy to Aβ42
- (2017) Camilla Lauridsen et al. Frontiers in Aging Neuroscience
- Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
- (2017) Franc Llorens et al. Frontiers in Aging Neuroscience
- Association of Cerebrospinal Fluid Ferritin Level With Preclinical Cognitive Decline in APOE-ε4 Carriers
- (2017) Scott Ayton et al. JAMA Neurology
- The Multifaceted Role of SNARE Proteins in Membrane Fusion
- (2017) Jing Han et al. Frontiers in Physiology
- Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
- (2017) Sarah Jesse et al. JOURNAL OF ALZHEIMERS DISEASE
- Conceptual Evolution in Alzheimer's Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative Disease
- (2017) Gregory A. Jicha et al. JOURNAL OF ALZHEIMERS DISEASE
- Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline
- (2017) Cristoforo Comi et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
- (2016) Erika Bereczki et al. Alzheimers & Dementia
- TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
- (2016) Bryan D. James et al. BRAIN
- TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing
- (2016) Kirsty E. McAleese et al. BRAIN PATHOLOGY
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease
- (2016) Joyce Tran et al. FEBS LETTERS
- Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer’s Disease and Dementia with Lewy Bodies
- (2016) Olivier Bousiges et al. JOURNAL OF ALZHEIMERS DISEASE
- Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers
- (2016) Lele Xu et al. JOURNAL OF ALZHEIMERS DISEASE
- Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment
- (2016) Mirjana Babić Leko et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors
- (2016) Amado Rivero-Santana et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease
- (2016) Theresa A. Lusardi et al. JOURNAL OF ALZHEIMERS DISEASE
- Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
- (2016) Carlo Cervellati et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer’s disease and in mild cognitive impairment due to AD
- (2016) Cristina Sanfilippo et al. JOURNAL OF NEURAL TRANSMISSION
- Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology
- (2016) Trevor Tyson et al. JOURNAL OF NEUROCHEMISTRY
- Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration
- (2016) Caitlin M. Kirkwood et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty
- (2016) Qingwei Ruan et al. Molecular Medicine Reports
- CSF microRNA Profiling in Alzheimer’s Disease: a Screening and Validation Study
- (2016) Adrià Dangla-Valls et al. MOLECULAR NEUROBIOLOGY
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- Biomarker bei Demenzen und anderen neurodegenerativen Erkrankungen
- (2016) J. Wiltfang et al. NERVENARZT
- Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
- (2016) Keun-A Chang et al. NEUROCHEMISTRY INTERNATIONAL
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
- (2016) Julia Remnestål et al. Proteomics Clinical Applications
- Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
- (2016) Niklas Mattsson et al. Nature Communications
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
- (2016) Malin Degerman Gunnarsson et al. Alzheimers Research & Therapy
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease
- (2016) Simona Magi et al. Biomed Research International
- Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
- (2016) Simone Lista et al. Expert Review of Neurotherapeutics
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer’s disease pathology
- (2016) R W Paterson et al. Translational Psychiatry
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
- (2016) Sofie Sølvsten Sørensen et al. Translational Neurodegeneration
- microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration
- (2016) Surjyadipta Bhattacharjee et al. PLoS One
- Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
- (2016) J. M. G. van Bergen et al. Scientific Reports
- Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
- (2015) Maike Hartlage-Rübsamen et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia
- (2015) Panos Roussos et al. Alzheimers & Dementia
- The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease
- (2015) Christina M. Lill et al. Alzheimers & Dementia
- CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
- (2015) Michael Ewers et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
- (2015) Heather M. Snyder et al. Alzheimers & Dementia
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
- (2015) Zheng-Yu Wang et al. INTERNATIONAL PSYCHOGERIATRICS
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
- (2015) Guillermo Moya-Alvarado et al. MOLECULAR & CELLULAR PROTEOMICS
- The Role of TDP-43 in Alzheimer’s Disease
- (2015) Xiao-Long Chang et al. MOLECULAR NEUROBIOLOGY
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- TREM2 analysis and increased risk of Alzheimer's disease
- (2015) Deana Finelli et al. NEUROBIOLOGY OF AGING
- More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk
- (2015) Samantha L. Rosenthal et al. NEUROBIOLOGY OF AGING
- Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles
- (2015) Luigi Yuri Di Marco et al. NEUROBIOLOGY OF DISEASE
- Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
- (2015) Daniel Alcolea et al. NEUROLOGY
- Synaptic protein levels altered in vascular dementia
- (2015) Lindsey I. Sinclair et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Cognitive impairments and neuronal injury in different brain regions of a genetic rat model of absence epilepsy
- (2015) M. Jafarian et al. NEUROSCIENCE
- Exploring the Alzheimer amyloid-β peptide conformational ensemble: A review of molecular dynamics approaches
- (2015) Linh Tran et al. PEPTIDES
- The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
- (2015) Malin Wennström et al. PLoS One
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker
- (2015) Zhihui Yang et al. TRENDS IN NEUROSCIENCES
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
- (2015) Scott Ayton et al. Nature Communications
- Neurogranin regulates CaM dynamics at dendritic spines
- (2015) Amber Petersen et al. Scientific Reports
- Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
- (2015) Maartje I. Kester et al. Alzheimers Research & Therapy
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease
- (2015) Rawan Tarawneh et al. JAMA Neurology
- Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
- (2015) Aline Dorey et al. Frontiers in Neurology
- MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
- (2015) Johannes Denk et al. PLoS One
- R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia
- (2014) Catherine F. Slattery et al. Alzheimers & Dementia
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer’s disease
- (2014) CHEN-GENG LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies
- (2014) Pradip K. Kamat et al. MOLECULAR NEUROBIOLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
- (2014) Shichun Tu et al. Molecular Neurodegeneration
- MRI for Iron Mapping in Alzheimer's Disease
- (2014) Christian Langkammer et al. Neurodegenerative Diseases
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?
- (2014) Diana Luque-Contreras et al. Oxidative Medicine and Cellular Longevity
- Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
- (2014) Kasandra Burgos et al. PLoS One
- Alpha-synuclein biology in Lewy body diseases
- (2014) Woojin Scott Kim et al. Alzheimers Research & Therapy
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- Biomarkers in neurodegenerative disorders: translating research into clinical practice
- (2014) Manuel Menéndez-González Frontiers in Aging Neuroscience
- Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
- (2014) Daniel Ferreira et al. Frontiers in Aging Neuroscience
- Protein phosphatase 2A dysfunction in Alzheimer’s disease
- (2014) Jean-Marie Sontag et al. Frontiers in Molecular Neuroscience
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Staging TDP-43 pathology in Alzheimer’s disease
- (2013) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- Plasma Proteomics for the Identification of Alzheimer Disease
- (2013) Liang-Hao Guo et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease
- (2013) Robert Perneczky et al. Alzheimers & Dementia
- Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
- (2013) Shambhunath Bose et al. ARCHIVES OF PHARMACAL RESEARCH
- Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
- (2013) Harald Hampel et al. BIOCHEMICAL PHARMACOLOGY
- Dyslipidemia and the Risk of Alzheimer’s Disease
- (2013) Christiane Reitz Current Atherosclerosis Reports
- Evaluation of the Cerebrospinal Fluid Amyloid-�1-42/Amyloid-�1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
- (2013) Magdalena Nutu et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies
- (2013) Xinni Luo et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils
- (2013) Lei Gu et al. JOURNAL OF NEUROCHEMISTRY
- Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
- (2013) Yuan Sun et al. MEDIATORS OF INFLAMMATION
- CSF biomarkers for Alzheimer’s pathology and the effect size of APOE ɛ4
- (2013) U Andreasson et al. MOLECULAR PSYCHIATRY
- Comparación de la capacidad diagnóstica precoz de los biomarcadores de la enfermedad de Alzheimer en resonancia magnética cerebral y líquido cefalorraquídeo
- (2013) J.A. Monge Argilés et al. NEUROLOGIA
- Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
- (2013) C. Sala Frigerio et al. NEUROLOGY
- Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal
- (2013) R. O. Roberts et al. NEUROLOGY
- GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
- (2013) Carlos Cruchaga et al. NEURON
- The Correlation of Hippocampal T2-Mapping with Neuropsychology Test in Patients with Alzheimer’s Disease
- (2013) Zhuren Luo et al. PLoS One
- The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease
- (2013) Elisabeth Kapaki et al. PLoS One
- Recent developments of protein kinase inhibitors as potential AD therapeutics
- (2013) Volkmar Tell et al. Frontiers in Cellular Neuroscience
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies
- (2012) Lih-Fen Lue et al. BRAIN PATHOLOGY
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis
- (2012) Christopher Carroll et al. EMERGENCY MEDICINE JOURNAL
- Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration
- (2012) Basar Cenik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neurofilaments at a glance
- (2012) A. Yuan et al. JOURNAL OF CELL SCIENCE
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The SNARE complex in neuronal and sensory cells
- (2012) Neeliyath A. Ramakrishnan et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
- (2012) T. T. Seppala et al. NEUROLOGY
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Variant TREM2 as Risk Factor for Alzheimer's Disease
- (2012) Harald Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
- (2012) Karin Westin et al. PLoS One
- Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
- (2012) Christian Czech et al. PLoS One
- Neurogranin Targets Calmodulin and Lowers the Threshold for the Induction of Long-Term Potentiation
- (2012) Ling Zhong et al. PLoS One
- Synapses and Alzheimer's Disease
- (2012) M. Sheng et al. Cold Spring Harbor Perspectives in Biology
- Osteopontin: A key link between immunity, inflammation and the central nervous system
- (2012) Amanda Brown Translational Neuroscience
- The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease—old wine in new bottles
- (2012) Karl H. Braunewell Frontiers in Molecular Neuroscience
- Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
- (2011) Fuyuki Tateno et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
- (2011) Michael W. Weiner et al. Alzheimers & Dementia
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- Chemokines in CSF of Alzheimer's disease patients
- (2011) Jôice Dias Corrêa et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration
- (2011) Massimiliano M. Corsi et al. BIOGERONTOLOGY
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- (2011) Argonde C. van Harten et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells
- (2011) Chun-Chuan Chen et al. CLINICAL IMMUNOLOGY
- Progression from Mild to Pronounced MCI Is Not Associated with Cerebrospinal Fluid Biomarker Deviations
- (2011) A. Wallin et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Distinguishing Alzheimer’s disease from other major forms of dementia
- (2011) Stella Karantzoulis et al. Expert Review of Neurotherapeutics
- Progranulin and TDP-43: Mechanistic Links and Future Directions
- (2011) Samir Kumar-Singh JOURNAL OF MOLECULAR NEUROSCIENCE
- Cellular Effects of Progranulin in Health and Disease
- (2011) Louis De Muynck et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease
- (2011) Cyntia Tremblay et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers
- (2011) Maartje I. Kester et al. NEUROBIOLOGY OF AGING
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- GFAP in health and disease
- (2011) J. Middeldorp et al. PROGRESS IN NEUROBIOLOGY
- Synaptic Vesicle Exocytosis
- (2011) T. C. Sudhof et al. Cold Spring Harbor Perspectives in Biology
- Cerebral atrophy, apolipoprotein E ɛ4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment
- (2010) Ozioma C. Okonkwo et al. Alzheimers & Dementia
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
- (2010) P.E. Spies et al. Current Alzheimer Research
- Alzheimer Disease
- (2010) Rudy J. Castellani et al. DM DISEASE-A-MONTH
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
- (2010) Inna Kuperstein et al. EMBO JOURNAL
- Fatty acid binding proteins in brain development and disease
- (2010) Rong-Zong Liu et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein
- (2010) Jens Kuhle et al. JOURNAL OF NEUROIMMUNOLOGY
- Differential levels of -synuclein, -amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- (2010) K. Kasuga et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuropathology of Alzheimer's Disease
- (2010) Daniel P. Perl MOUNT SINAI JOURNAL OF MEDICINE
- TAR DNA-binding protein 43 in neurodegenerative disease
- (2010) Alice S. Chen-Plotkin et al. Nature Reviews Neurology
- Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
- (2010) Elmar Kaiser et al. Neurodegenerative Diseases
- Identifying and validating biomarkers for Alzheimer's disease
- (2010) Christian Humpel TRENDS IN BIOTECHNOLOGY
- What are biomarkers?
- (2010) Kyle Strimbu et al. Current Opinion in HIV and AIDS
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
- Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson’s Disease
- (2009) Steven R. Danielson et al. ANALYTICAL CHEMISTRY
- A novel recessiveNeflmutation causes a severe, early-onset axonal neuropathy
- (2009) Sabrina W. Yum et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification
- (2009) Hyun-Ju Cho et al. Current Atherosclerosis Reports
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks
- (2009) Bridgette D Semple et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease
- (2009) Bei Ding et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies
- (2009) A J Mitchell JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilaments Form a Highly Stable Stationary Cytoskeleton after Reaching a Critical Level in Axons
- (2009) A. Yuan et al. JOURNAL OF NEUROSCIENCE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Calcium signaling in neurodegeneration
- (2009) Philippe Marambaud et al. Molecular Neurodegeneration
- Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease
- (2009) B. Schmand et al. PSYCHOLOGICAL MEDICINE
- Quantitative MR Phase-corrected Imaging to Investigate Increased Brain Iron Deposition of Patients with Alzheimer Disease
- (2009) Wen-zhen Zhu et al. RADIOLOGY
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases
- (2008) Catherine M. Cahill et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
- (2008) Michael Ewers et al. BRAIN
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
- (2008) Laura Piccio et al. BRAIN
- CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
- (2008) Moeko Noguchi-Shinohara et al. BRAIN RESEARCH
- Decrease in age-adjusted cerebrospinal fluid β-secretase activity in Alzheimer's subjects
- (2008) Guoxin Wu et al. CLINICAL BIOCHEMISTRY
- The Brain Injury Biomarker VLP-1 Is Increased in the Cerebrospinal Fluid of Alzheimer Disease Patients
- (2008) J.-M. Lee et al. CLINICAL CHEMISTRY
- Osteopontin: Role in immune regulation and stress responses
- (2008) Kathryn X. Wang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CSF biomarker profile and diagnostic value in vascular dementia
- (2008) G. P. Paraskevas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- TDP-43 in neurodegenerative disorders
- (2008) Casey Cook et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia
- (2008) Mattsson Molecular Medicine Reports
- Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
- (2008) N. Brouwers et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Beta‐site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease
- (2008) Harald Hampel et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
- (2008) J. Sreedharan et al. SCIENCE
- Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
- (2008) Breno S. O. Diniz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search